1Topol EJ,Yadav JS.Recognition of the importance of embolization in atherosclerotic vascular disease[J].Circulation,2000,101(5):570 -580.
2Piana RN,Paik GY,Moscucci M,et al.Incidence and treatment of no-reflow after percutaneous coronary intervention[J].Circulation,1994,89(6):2514-2518.
3Abbo KM,Dooris M,Glazier S,et al.Features and outcome of no-reflow after percutaneous coronary intervention[J].Am J Cardiol,1995,75(12):778-782.
4Yip HK,Chen MC,Chang HW,et al.Angiographic morphologic features of infarct related arteries and timely reperfusion in acute myocardial infarction:predictors of slow-flow and no-reflow phenomenon[J].Chest,2002,122(4):1322-1332.
5Weyrens FJ,Mooney J,Lesser J,et al.Intracoronary diltiazem for microvascular spasm after interventional therapy[J].Am J Cardiol,1995,75(12):849-850.
6Yang TY,Chang ST,Chung CM,et al.Restoration of normal coronary flow with tirofiban by intracoronary administration for no-reflow phenomenon after stent deployment.[J].Int Heart J,2005,46(1):139-145.
8Grande P, Grauhoh AM, Madsen JK, et al. Unstable angina pector is platelets behavior and prognosis in progressive angina and intermediate coronary syndrome [J]. Circulation, 1990, 81 (Suppll) : 116.
9Peter K, Nordt T, Bode CI. Therapeutic inhibition of platelets in a acute coronary syndrome and in coronary intervention: mechanisms and clinical results [J]. Cardiol, 2000, 89 (Suppl7) : 601.
10Ganesh S. Tirofiban and emergency coronary surgery [J]. Eur J Cardiothorac Surg, 2005, 28: 546-550.
